D.B. Root & Company, LLC Biomarin Pharmaceutical Inc Transaction History

D.B. Root & Company, LLC

$292 Million
Q1 2024

A detailed history of D.B. Root & Company, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, D.B. Root & Company, LLC holds 4,011 shares of BMRN stock, worth $326,695. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,011

Previous 4,011 -0.0%

Holding current value

$326,695

Previous $386,000 9.33%

% of portfolio

0.12%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$76.22 - $98.51 $30,106 - $38,911	-395 Reduced 8.97%	4,011 $386,000
Q3 2023 Nov 03, 2023	BUY	$85.07 - $94.48 $2,807 - $3,117	33 Added 0.75%	4,406 $389,000
Q2 2023 Jul 18, 2023	BUY	$86.68 - $100.3 $25,137 - $29,087	290 Added 7.1%	4,373 $379,000
Q1 2023 Apr 18, 2023	BUY	$87.74 - $117.27 $87 - $117	1 Added 0.02%	4,083 $397,000
Q4 2022 Jan 27, 2023	SELL	$80.93 - $108.63 $24,198 - $32,480	-299 Reduced 6.82%	4,082 $0

Q3 2022 Oct 26, 2022	SELL	$82.16 - $96.94 $575 - $678	-7 Reduced 0.16%	4,381 $371,000
Q2 2022 Jul 21, 2022	SELL	$71.48 - $86.85 $230,380 - $279,917	-3,223 Reduced 42.35%	4,388 $363,000
Q1 2022 May 06, 2022	BUY	$74.28 - $92.69 $2,525 - $3,151	34 Added 0.45%	7,611 $586,000
Q4 2021 Feb 01, 2022	SELL	$71.72 - $91.47 $10,901 - $13,903	-152 Reduced 1.97%	7,577 $669,000
Q3 2021 Oct 22, 2021	SELL	$74.77 - $85.47 $113,725 - $129,999	-1,521 Reduced 16.44%	7,729 $597,000
Q2 2021 Jul 28, 2021	SELL	$75.51 - $84.79 $6,191 - $6,952	-82 Reduced 0.88%	9,250 $771,000
Q1 2021 May 04, 2021	BUY	$74.73 - $90.69 $174,569 - $211,851	2,336 Added 33.39%	9,332 $704,000
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $1,887 - $2,345	-26 Reduced 0.37%	6,996 $613,000
Q3 2020 Oct 22, 2020	BUY	$71.87 - $131.03 $56,274 - $102,596	783 Added 12.55%	7,022 $534,000
Q2 2020 Aug 06, 2020	SELL	$79.55 - $124.22 $17,501 - $27,328	-220 Reduced 3.41%	6,239 $769,000
Q1 2020 Apr 29, 2020	BUY	$71.37 - $96.85 $19,626 - $26,633	275 Added 4.45%	6,459 $545,000
Q4 2019 Jan 14, 2020	BUY	$64.27 - $86.37 $145,250 - $195,196	2,260 Added 57.59%	6,184 $522,000
Q3 2019 Oct 29, 2019	SELL	$67.4 - $85.11 $11,795 - $14,894	-175 Reduced 4.27%	3,924 $264,000
Q2 2019 Jul 19, 2019	SELL	$80.35 - $93.9 $3,615 - $4,225	-45 Reduced 1.09%	4,099 $351,000
Q1 2019 Apr 12, 2019	BUY	$84.2 - $98.62 $33,174 - $38,856	394 Added 10.51%	4,144 $368,000
Q4 2018 Jan 25, 2019	SELL	$80.14 - $106.07 $224,392 - $296,996	-2,800 Reduced 42.75%	3,750 $319,000
Q3 2018 Nov 05, 2018	SELL	$93.92 - $105.72 $198,171 - $223,069	-2,110 Reduced 24.36%	6,550 $635,000
Q2 2018 Jul 25, 2018	BUY	$76.01 - $99.03 $26,223 - $34,165	345 Added 4.15%	8,660 $816,000
Q1 2018 May 02, 2018	BUY	$77.67 - $92.63 $645,826 - $770,218	8,315 New	8,315 $674,000

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on D.B. Root & Company, LLC with notifications on news.

Account

D.B. Root & Company, LLC Biomarin Pharmaceutical Inc Transaction History